Ушбу ишга иқтибос қилган ишлар

5 та иш

Иш: Inflammation and immune dysfunction in Parkinson disease

1. Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease

   Alexander V. Blagov, Anton Y. Postnov, Vasily N. Sukhorukov +3

   МақолаParkinson's Disease Mechanisms and TreatmentsFrontiers in Bioscience-Landmark20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.000294

2. Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells for Parkinson’s Therapy: From Developmental Insights to Application

   Zhe Wang, Qingtong Yu, Wenwen Deng +3

   МақолаMesenchymal stem cell researchTissue Engineering Part B Reviews20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.008644

3. Treatment of Parkinson’s Disease with an Anti-Inflammasome NLRP3 Inhibitor Derived from a Natural Product

   Wenqian Li, Jiu‐liang Zhang, Qiang Chen +13

   МақолаInflammasome and immune disordersACS Pharmacology & Translational Science20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009063

4. Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling

   Mohamed J. Saadh, Tamara Nazar Saeed, Ali Fawzi Al-Hussainy +9

   Шарҳ мақолаCoenzyme Q10 studies and effectsArchives of Physiology and Biochemistry20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000117

5. Peripheral Iron and Immune Markers Are Associated With Levodopa-Induced Dyskinesia Severity in Parkinson’s Disease

   F.S. Saidvaliyev, Dilyora Pulatova, I.A. Kilichev +8

   ПрепринтParkinson's Disease Mechanisms and TreatmentsResearch Square20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.preprint.000840